Trabectedin for recurrent grade 2 or 3 meningiomas episode artwork

EPISODE · Jan 28, 2022 · 17 MIN

Trabectedin for recurrent grade 2 or 3 meningiomas

from Neuro-Oncology: The Podcast · host Dr. Iyad Alnahhas, Dr. Matthias Preusser

Dr. Iyad Alnahhas interviews Dr. Matthias Preusser about the recent manuscript entitled: "Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)", published online in Neuro-Oncology in October 2021.

NOW PLAYING

Trabectedin for recurrent grade 2 or 3 meningiomas

0:00 17:06

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Neuro-Oncology: The Podcast?

This episode is 17 minutes long.

When was this Neuro-Oncology: The Podcast episode published?

This episode was published on January 28, 2022.

What is this episode about?

Dr. Iyad Alnahhas interviews Dr. Matthias Preusser about the recent manuscript entitled: "Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)", published online in...

Can I download this Neuro-Oncology: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!